Abstract:Pathological scarring resulting from traumas and wounds, such as hypertrophic scars and keloids, pose significant aesthetic, functional and psychological challenges. This study provides a comprehensive transcriptomic analysis of these conditions, aiming to illuminate underlying molecular mechanisms and potential therapeutic targets. We employed a co-expression and module analysis tool to identify significant gene clusters associated with distinct pathophysiological processes and mechanisms, notably lipid metabolism, sebum production, cellular energy metabolism and skin barrier function. This examination yielded critical insights into several skin conditions including folliculitis, skin fibrosis, fibrosarcoma and congenital ichthyosis. Particular attention was paid to Module Cluster (MCluster) 3, encompassing genes like BLK, TRPV1 and GABRD, all displaying high expression and potential implications in immune modulation. Preliminary immunohistochemistry validation supported these findings, showing elevated expression of these genes in non-fibrotic samples rich in immune activity. The complex interplay of different cell types in scar formation, such as fibroblasts, myofibroblasts, keratinocytes and mast cells, was also explored, revealing promising therapeutic strategies. This study underscores the promise of targeted gene therapy for pathological scars, paving the way for more personalised therapeutic approaches. The results necessitate further research to fully ascertain the roles of these identified genes and pathways in skin disease pathogenesis and potential therapeutics. Nonetheless, our work forms a strong foundation for a new era of personalised medicine for patients suffering from pathological scarring.

Mechanisms and Therapies

Emerging biomedical technologies for scarless wound healing

Recent innovations to inhibit scar formation for better skin regeneration

Toward understanding scarless skin wound healing and pathological scarring

Cellular and molecular mechanisms of skin wound healing

An Update on Molecular Mechanisms of Scarring—A Narrative Review

Fibroblasts: Heterogeneous Cells With Potential in Regenerative Therapy for Scarless Wound Healing

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis

Novel Prospects for Scarless Wound Healing: the Roles of Myofibroblasts and Adipocytes.

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

Clinical Management of Wound Healing and Hypertrophic Scarring

Improved Dermal Regeneration Using a Combination of Dermal Substitutes and Dermal Fibroblast Optimization: A Hypothesis.

Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis

Application of ADSCs and their Exosomes in Scar Prevention

Embryonic skin development and repair

The Progress and Challenges for Dermal Regeneration in Tissue Engineering.

New insights into the roles of myofibroblasts and innervation during skin healing and innovative therapies to improve scar innervation

Nature-Inspired Scarless Healing: Guiding Biomaterials Design for Advanced Therapies

Biomaterial-based mechanical regulation facilitates scarless wound healing with functional skin appendage regeneration

Advances in scarless foetal wound healing and prospects for scar reduction in adults